Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › Abbott Acquisition of Alere Cleared by European Commission

Abbott Acquisition of Alere Cleared by European Commission

Jan 25, 2017
|
staff reporter

NEW YORK (GenomeWeb) – Alere said today that the European Commission has granted clearance for its acquisition by Abbott.

The announcement came almost immediately after Abbott completed its fourth quarter earnings call, which was notable in part for its relative silence about the proposed Alere acquisition.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Feb
23
Featured Webinar

After the Surge: Driving Sample Processing Efficiency of Coronavirus Samples

Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

Feb
26
Featured Webinar

Responding to Emerging SARS-CoV-2 Variants: The Impact on Existing Diagnostic Testing and the Clinical Utility of Differentiation Assays

As new variants of SARS-CoV-2 circulate around the globe, there is growing concern among clinical laboratories that these variants may impact their ability to accurately detect the virus.  

What's Popular?

In Molecular Diagnostics

  1. Bio-Rad, United Biomedical Get FDA Emergency Use Authorizations for Coronavirus Tests

  2. Thermo Fisher Scientific to Acquire Mesa Biotech for Up to $550M

  3. CMS Finalizes Blood-Based Colon Cancer Screening NCD with Non-Coverage for Epi ProColon

  4. Jonathan Rothberg-Led Startup Looks to Bring Disposable POC SARS-CoV-2 Test to Market

    Premium

  5. Invitae to Raise $400M in Proposed Public Offering

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.